USA - NASDAQ:UG - US9105711082 - Common Stock
The current stock price of UG is 7.37 USD. In the past month the price decreased by -5.13%. In the past year, price decreased by -43.86%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| UL | UNILEVER PLC-SPONSORED ADR | 23.82 | 153.00B | ||
| EL | ESTEE LAUDER COMPANIES-CL A | 67.37 | 36.42B | ||
| KVUE | KENVUE INC | 13.98 | 28.72B | ||
| ELF | ELF BEAUTY INC | 39.79 | 7.18B | ||
| BRBR | BELLRING BRANDS INC | 14.51 | 3.97B | ||
| COTY | COTY INC-CL A | 18.84 | 3.62B | ||
| IPAR | INTERPARFUMS INC | 18.88 | 3.11B | ||
| ODD | ODDITY TECH LTD-CL A | 22.02 | 2.69B | ||
| EPC | EDGEWELL PERSONAL CARE CO | 7.62 | 912.94M | ||
| HLF | HERBALIFE LTD | 3.96 | 860.97M | ||
| YSG | YATSEN HOLDING LTD-ADR | N/A | 741.16M | ||
| OLPX | OLAPLEX HOLDINGS INC | 13.81 | 737.12M |
United-Guardian, Inc. engages in the development and manufacture of pharmaceuticals, cosmetic ingredients, personal and health care products and medical devices. The company is headquartered in Hauppauge, New York and currently employs 24 full-time employees. The Company’s product lines include the Lubrajel line of multifunctional hydrogel formulations, which are designed to provide sensory enhancement, lubrication, hydration, and texture to both personal care and medical products. Its four distinct product categories include cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. Its COSMOS line of products includes Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural, and Lubrajel Terra. Its medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. The Company’s pharmaceutical products include an FDA-approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial.
UNITED GUARDIAN INC
230 Marcus Blvd
Hauppauge NEW YORK 11788 US
CEO: Ken Globus
Employees: 25
Phone: 16312730900
United-Guardian, Inc. engages in the development and manufacture of pharmaceuticals, cosmetic ingredients, personal and health care products and medical devices. The company is headquartered in Hauppauge, New York and currently employs 24 full-time employees. The Company’s product lines include the Lubrajel line of multifunctional hydrogel formulations, which are designed to provide sensory enhancement, lubrication, hydration, and texture to both personal care and medical products. Its four distinct product categories include cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. Its COSMOS line of products includes Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural, and Lubrajel Terra. Its medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. The Company’s pharmaceutical products include an FDA-approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial.
The current stock price of UG is 7.37 USD. The price increased by 0.14% in the last trading session.
UNITED GUARDIAN INC (UG) has a dividend yield of 6.51%. The yearly dividend amount is currently 0.6.
UG has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
UG stock is listed on the Nasdaq exchange.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on UG.
UNITED GUARDIAN INC (UG) has a market capitalization of 33.83M USD. This makes UG a Nano Cap stock.
ChartMill assigns a fundamental rating of 6 / 10 to UG. UG gets an excellent profitability rating and is at the same time showing great financial health properties.
Over the last trailing twelve months UG reported a non-GAAP Earnings per Share(EPS) of 0.56. The EPS decreased by -21.62% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 23.55% | ||
| ROA | 19.09% | ||
| ROE | 22.31% | ||
| Debt/Equity | 0 |